Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. HYPR
stocks logo

HYPR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
5.01M
+115.64%
-0.080
-42.86%
3.40M
+59.1%
-0.090
-25%
3.70M
+37.24%
-0.090
-25%
Estimates Revision
The market is revising Downward the revenue expectations for Hyperfine, Inc. (HYPR) for FY2025, with the revenue forecasts being adjusted by -0.35% over the past three months. During the same period, the stock price has changed by -15.30%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.35%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-1.16%
In Past 3 Month
Stock Price
Go Down
down Image
-15.30%
In Past 3 Month
Wall Street analysts forecast HYPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYPR is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast HYPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYPR is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.991
sliders
Low
2.00
Averages
2.00
High
2.00
Current: 0.991
sliders
Low
2.00
Averages
2.00
High
2.00
Lake Street
Buy
maintain
$2
2025-08-14
Reason
Lake Street
Price Target
$2
2025-08-14
maintain
Buy
Reason
Lake Street raised the firm's price target on Hyperfine to $2 from $1.50 and keeps a Buy rating on the shares after the company reported Q2 results and reiterated 2025 guidance for 10%-20% revenue growth. The firm believes a growth inflection supports multiple expansion, the analyst tells investors in a post-earnings note.
B. Riley
Yuan Zhi
Buy
maintain
$1
2025-06-03
Reason
B. Riley
Yuan Zhi
Price Target
$1
2025-06-03
maintain
Buy
Reason
B. Riley
Buy
downgrade
$1
2025-05-15
Reason
B. Riley
Price Target
$1
2025-05-15
downgrade
Buy
Reason
B. Riley lowered the firm's price target on Hyperfine to $1 from $1.20 and keeps a Buy rating on the shares. The Q1 sales miss was driven by the loss of several orders at large academic institutions that were funded by research grants, which was a result of the tension between academic institutions and the current administration, the analyst tells investors in a research note. The firm awaits more clarity in the second half of 2025.
Lake Street
Frank Takkinen
Strong Buy
Initiates
$1.5
2025-03-24
Reason
Lake Street
Frank Takkinen
Price Target
$1.5
2025-03-24
Initiates
Strong Buy
Reason
B. Riley Securities
Yuan Zhi
Strong Buy
Maintains
$1.5 → $1.2
2025-03-20
Reason
B. Riley Securities
Yuan Zhi
Price Target
$1.5 → $1.2
2025-03-20
Maintains
Strong Buy
Reason
B. Riley analyst Yuan Zhi lowered the firm's price target on Hyperfine to $1.20 from $1.50 and keeps a Buy rating on the shares. The top-line miss in in Q4 was driven by extended timelines in legacy critical care business, and guidance for the first half of 2025 implies a continued slowdown, while 2025 guidance implies a sharp revenue increase in the second half of the year, the analyst tells investors in a research note. Uncertainty remains, and management will have more visibility in the coming months amid new sales reps and new opportunities, the firm adds.
Wells Fargo
Larry Biegelsen
Hold
Maintains
$1.1 → $1.29
2025-03-18
Reason
Wells Fargo
Larry Biegelsen
Price Target
$1.1 → $1.29
2025-03-18
Maintains
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Hyperfine Inc (HYPR.O) is -2.83, compared to its 5-year average forward P/E of -1.81. For a more detailed relative valuation and DCF analysis to assess Hyperfine Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.81
Current PE
-2.83
Overvalued PE
-0.57
Undervalued PE
-3.04

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.59
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.21
Undervalued EV/EBITDA
-2.38

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
7.04
Current PS
0.00
Overvalued PS
15.72
Undervalued PS
-1.64
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

HYPR News & Events

Events Timeline

(ET)
2025-11-13
16:09:03
Hyperfine announces Q3 earnings per share of 14 cents, unchanged from last year.
select
2025-10-21 (ET)
2025-10-21
09:06:45
Hyperfine begins enrollment of first patient in PRISM PMR study
select
2025-10-16 (ET)
2025-10-16
08:35:32
Hyperfine's 14 Million Share Spot Secondary Offering Set at $1.25
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
11-19Newsfilter
Hyperfine Receives $3.7 Million Grant to Promote Global Brain Health

  • AI-Powered Portable MRI Initiative: Hyperfine, Inc. has received a $3.7 million grant from the Gates Foundation to enhance the use of its AI-powered portable MRI system, Swoop®, for evaluating childhood brain development in underserved communities through neonatal scanning.

  • Focus on Neurodevelopment: The UNITY project, led by King's College London, aims to assess neurodevelopment in infants and young children in resource-constrained settings, addressing risks such as malnutrition and health adversities that can lead to impaired brain development.

  • Scalable Solutions for Global Health: The Swoop® system provides a cost-effective and scalable method for objectively assessing early brain development, enabling real-time insights for clinicians to improve treatment and health interventions for children globally.

  • Collaboration and Future Goals: The partnership with King's College London will focus on developing AI-based improvements for image clarity and diagnostic reliability, with the goal of optimizing treatment for neonatal patients in various countries, including Malawi, Ghana, and India.

[object Object]
Preview
9.5
11-13NASDAQ.COM
After-Hours Movers: MGNX, SLS, KRMD, HYPR, WVE Experience Significant Changes After Q3 Reports

  • MacroGenics Earnings Report: MacroGenics, Inc. saw a 10.2% increase in after-hours trading, reporting a third-quarter net income of $16.8 million, down from $56.3 million year-over-year, with revenue falling to $72.8 million.

  • SELLAS Life Sciences Update: SELLAS Life Sciences Group, Inc. rose 9.4% after narrowing its quarterly net loss to $6.8 million, with cash and equivalents reported at approximately $44.3 million as of September 30, 2025.

  • KORU Medical Systems Performance: KORU Medical Systems, Inc. gained 8.47% after reporting a narrower net loss of $0.8 million and a 27.2% revenue increase to $10.4 million, while raising its full-year revenue guidance.

  • Wave Life Sciences Results: Wave Life Sciences Ltd. increased by 5.68% after reporting a third-quarter net loss of $53.9 million, an improvement from the previous year, with revenue of $7.6 million.

[object Object]
Preview
9.5
11-13NASDAQ.COM
Electromed, Inc. (ELMD) Exceeds Q1 Earnings and Revenue Projections

  • Earnings Performance: Electromed, Inc. (ELMD) reported quarterly earnings of $0.25 per share, exceeding the Zacks Consensus Estimate of $0.22, and showing an increase from $0.16 per share a year ago, marking a +13.64% earnings surprise.

  • Revenue Growth: The company generated revenues of $16.89 million for the quarter, surpassing the Zacks Consensus Estimate by 1.30% and up from $14.67 million in the previous year, with two instances of exceeding revenue estimates in the last four quarters.

  • Stock Outlook: Despite the positive earnings report, Electromed shares have declined by about 15% year-to-date, and the stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.

  • Industry Context: The Medical - Instruments industry, to which Electromed belongs, ranks in the top 29% of Zacks industries, suggesting that industry performance could significantly influence Electromed's stock trajectory moving forward.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Hyperfine Inc (HYPR) stock price today?

The current price of HYPR is 0.991 USD — it has increased 5.43 % in the last trading day.

arrow icon

What is Hyperfine Inc (HYPR)'s business?

Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.

arrow icon

What is the price predicton of HYPR Stock?

Wall Street analysts forecast HYPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HYPR is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Hyperfine Inc (HYPR)'s revenue for the last quarter?

Hyperfine Inc revenue for the last quarter amounts to 3.44M USD, decreased -5.65 % YoY.

arrow icon

What is Hyperfine Inc (HYPR)'s earnings per share (EPS) for the last quarter?

Hyperfine Inc. EPS for the last quarter amounts to -0.14 USD, decreased -0.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Hyperfine Inc (HYPR)'s fundamentals?

The market is revising Downward the revenue expectations for Hyperfine, Inc. (HYPR) for FY2025, with the revenue forecasts being adjusted by -0.35% over the past three months. During the same period, the stock price has changed by -15.30%.
arrow icon

How many employees does Hyperfine Inc (HYPR). have?

Hyperfine Inc (HYPR) has 111 emplpoyees as of December 05 2025.

arrow icon

What is Hyperfine Inc (HYPR) market cap?

Today HYPR has the market capitalization of 96.29M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free